Tag: FDA digital drugs
Asher Clyne
Digital Therapeutics and Medication Interactions: What You Need to Know in 2026
Digital therapeutics are changing how patients manage medications, boosting adherence and outcomes for chronic conditions. But they come with risks, access gaps, and regulatory uncertainty. Here's what you need to know in 2026.
Continue Reading